Ongoing Endothelial Cell Dysfunction Following Hemorrhagic Shock: Crystalloids are the Culprit

Area of Science:

• Trauma Resuscitation
• Critical Care Medicine
• Hemorrhagic Shock Management

Background:

• Current trauma care emphasizes early blood product use and limited crystalloid administration to improve outcomes.
• Limited data exists on the impact of crystalloid use following successful hemorrhage control.
• This study investigates the hypothesis that crystalloid administration during early post-resuscitation care may exacerbate endothelial dysfunction.

Purpose of the Study:

• To examine the association between crystalloid fluid administration in the post-hemorrhage control period and markers of endothelial dysfunction, coagulation, and inflammation.
• To evaluate the correlation between crystalloid volume and clinical outcomes such as organ failure and length of stay in the intensive care unit (ICU).

Main Methods:

• Prospective observational study of 69 patients in hemorrhagic shock.
• Collection of crystalloid administration data at arrival, in the operating room (OR), and at 24, 48, and 72 hours post-resuscitation in the ICU.
• Analysis of blood samples for indicators of inflammation, endothelial dysfunction (e.g., syndecan-1), and coagulation (e.g., INR) using Luminex assays.

Main Results:

• Patients received a mean of 4.7L of crystalloid within the first 24 hours, with significant volumes administered in the OR and ICU.
• Elevated endothelial, coagulation, and inflammatory markers were observed on admission compared to controls.
• Crystalloid volume at 24 hours correlated with syndecan-1 and INR, indicating persistent endothelial dysfunction.
• Later crystalloid totals (48h and 72h) correlated with increased Sequential Organ Failure Assessment (SOFA) scores, longer ICU stays, and more ventilator days.

Conclusions:

• Crystalloid administration persists even after hemorrhage control in clinical practice.
• This practice is associated with ongoing endothelial and coagulation dysfunctions.
• Alternative resuscitation strategies are needed for the post-hemorrhagic phase to mitigate these adverse effects.